A recent blog entry discussed a spate of reports, which demonstrated that investors are flooding into digital health, and less interested in traditional medical devices and pharmaceuticals.
A new report from CB Insights focuses on corporate investments in digital health, noting that “corporate investors from Google to Merck to BlueCross BlueShield are actively getting into the fray.”
This blog has started to discuss the emerging evidence base supporting digital health technologies, including telehealth. Despite Obamacare, many of these investments are likely to result in products and services that bend the curve of health spending.
Read the entire column at NCPA's Health Policy Blog.